Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

14.74

1.53 (11.58%)

At close: Aug 15, 2025, 3:59 PM

14.92

1.22%

After-hours: Aug 15, 2025, 07:58 PM EDT

11.58% (1D)

Bid	10.68
Market Cap	495.17M
Revenue (ttm)	n/a
Net Income (ttm)	-73.47M
EPS (ttm)	-6.24
PE Ratio (ttm)	-2.36
Forward PE	-4.15
Analyst	Buy

Ask	17.2
Volume	538,045
Avg. Volume (20D)	380,964
Open	13.90
Previous Close	13.21
Day's Range	13.04 - 15.05
52-Week Range	4.81 - 27.50
Beta	0.72

About MBX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MBX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MBX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+4.05%

MBX Biosciences shares are trading higher. The sto... Unlock content with Pro Subscription

News

2 days ago · seekingalpha.com

Microbix Biosystems Inc. (MBXBF) Q2 2025 Earnings Call Transcript

Microbix Biosystems Inc. (OTCQX:MBXBF) Q3 2025 Earnings Conference Call August 14, 2025 10:00 AM ET Company Participants Cameron L. Groome - President, CEO & Director James S.

1 week ago · fool.com

Mbx Biosciences (MBX) Q2 Loss Widens 22%

2 months ago · seekingalpha.com

MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy

MBX Biosciences offers a unique prodrug approach with three promising candidates targeting hypoparathyroidism, post-bariatric hypoglycemia, and obesity - two of its three drug candidates are GLP recep...